{"name": "Eurand",
 "permalink": "eurand",
 "crunchbase_url": "http://www.crunchbase.com/company/eurand",
 "homepage_url": "http://www.eurand.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "+31-20-6732744",
 "description": "",
 "created_at": "Sat Dec 04 06:13:51 UTC 2010",
 "updated_at": "Fri May 24 12:05:00 UTC 2013",
 "overview": "\u003Cp\u003EEurand N.V. (Eurand) is a holding company. The Company is a specialty pharmaceutical company that develops, manufactures and commercializes pharmaceutical and biopharmaceutical products. The Company is commercializing a portfolio of products for cystic fibrosis (CF) and gastrointestinal (GI) patients in the United States. As of December 31, 2009, it had two late-stage product candidates, EUR-1073 (beclomethasone) and EUR-1025 (ondansetron) in development in its own portfolio, as well as a number of other products in development with collaboration partners, including EUR-1000, which is partnered with GlaxoSmithKline (GSK). It has manufacturing and research facilities in the United States, Italy and France. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       59],
      "assets/images/resized/0011/2831/112831v2-max-150x150.png"],
     [[250,
       99],
      "assets/images/resized/0011/2831/112831v2-max-250x250.png"],
     [[278,
       111],
      "assets/images/resized/0011/2831/112831v2-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chairman of the Board, CEO",
    "person":
     {"first_name": "Gearoid",
      "last_name": "M. Faherty",
      "permalink": "gearoid-m-faherty",
      "image": null}},
   {"is_past": false,
    "title": "Senior Vice President and Chief Corporate Development Officer",
    "person":
     {"first_name": "Theresa",
      "last_name": "Stevens",
      "permalink": "theresa-stevens",
      "image":
       {"available_sizes":
         [[[80,
            95],
           "assets/images/resized/0026/6865/266865v1-max-150x150.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6865/266865v1-max-250x250.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6865/266865v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Senior Vice President and Chief Human Resources Officer",
    "person":
     {"first_name": "Richard",
      "last_name": "DeVleeschouwer",
      "permalink": "richard-devleeschouwer",
      "image":
       {"available_sizes":
         [[[80,
            95],
           "assets/images/resized/0026/6857/266857v1-max-150x150.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6857/266857v1-max-250x250.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6857/266857v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Senior Vice President, General Counsel \u0026 Corporate Secretary",
    "person":
     {"first_name": "Rick",
      "last_name": "Maroun",
      "permalink": "rick-maroun",
      "image":
       {"available_sizes":
         [[[80,
            95],
           "assets/images/resized/0026/6864/266864v1-max-150x150.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6864/266864v1-max-250x250.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6864/266864v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "CEO",
    "person":
     {"first_name": "John",
      "last_name": "Fraher",
      "permalink": "john-fraher",
      "image":
       {"available_sizes":
         [[[80,
            95],
           "assets/images/resized/0026/6823/266823v1-max-150x150.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6823/266823v1-max-250x250.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6823/266823v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Chief Research Officer",
    "person":
     {"first_name": "Robert",
      "last_name": "Becker",
      "permalink": "robert-becker",
      "image":
       {"available_sizes":
         [[[80,
            95],
           "assets/images/resized/0026/6859/266859v1-max-150x150.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6859/266859v1-max-250x250.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6859/266859v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Senior Vice President, Chief Financial Officer and Treasurer",
    "person":
     {"first_name": "Steve",
      "last_name": "Gannon",
      "permalink": "steve-gannon",
      "image":
       {"available_sizes":
         [[[80,
            95],
           "assets/images/resized/0026/6861/266861v1-max-150x150.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6861/266861v1-max-250x250.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6861/266861v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "President, International Specialty Pharmaceuticals",
    "person":
     {"first_name": "Jean",
      "last_name": "Louis Anspach",
      "permalink": "jean-louis-anspach",
      "image":
       {"available_sizes":
         [[[80,
            95],
           "assets/images/resized/0026/6821/266821v1-max-150x150.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6821/266821v1-max-250x250.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6821/266821v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "chief Medical Officer",
    "person":
     {"first_name": "Ruth",
      "last_name": "Thieroff-Ekerdt",
      "permalink": "ruth-thieroff-ekerdt",
      "image":
       {"available_sizes":
         [[[80,
            95],
           "assets/images/resized/0026/6866/266866v1-max-150x150.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6866/266866v1-max-250x250.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6866/266866v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "President, US Specialty Pharmaceuticals",
    "person":
     {"first_name": "David",
      "last_name": "W. Mims",
      "permalink": "david-w-mims",
      "image":
       {"available_sizes":
         [[[80,
            95],
           "assets/images/resized/0026/6825/266825v1-max-150x150.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6825/266825v1-max-250x250.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6825/266825v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 583000000.0,
   "price_currency_code": "USD",
   "term_code": "cash",
   "source_url": "http://www.thepressreleasewire.com/client/axcan/n/release.jsp?actionFor=1361779\u0026releaseSeq=0\u0026year=2010",
   "source_description": "Eurand to be Acquired by Axcan for $12.00 per Share in Cash",
   "acquired_year": 2010,
   "acquired_month": 12,
   "acquired_day": 1,
   "acquiring_company":
    {"name": "Aptalis Pharma",
     "permalink": "aptalis",
     "image":
      {"available_sizes":
        [[[150,
           59],
          "assets/images/resized/0011/2830/112830v2-max-150x150.png"],
         [[250,
           99],
          "assets/images/resized/0011/2830/112830v2-max-250x250.png"],
         [[278,
           111],
          "assets/images/resized/0011/2830/112830v2-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Olympic Plaza Fred",
    "address2": "Roeskestraat 123",
    "zip_code": "1076 EE",
    "city": "Amsterdam",
    "state_code": null,
    "country_code": "NLD",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}